Treatment-related Acute Esophagitis For Patients With Locoregionally Advanced Non–Small Cell Lung Cancer Treated With Involved-field Radiotherapy and Concurrent Chemotherapy

Abstract

Higher risk of grade ≥ 2 treatment-related esophagitis was associated with lower total esophageal volume and higher radiotherapy dose per fraction and should be taken into consideration during patient treatment planning. Inclusion of total esophageal volume and dose per fraction into future clinical protocols may further help our understanding of treatment-related esophagitis and enable the development of novel preventative approaches.